Skip to content

IDYA - IDEAYA Biosciences, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchI

Ideaya Biosciences Inc

IDYA · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

I

IDYAIdeaya Biosciences Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $40.58
52-wk low: $23.23
Prev close: $35.70
Mkt cap: $3.75B
Fwd P/E: 4.6x
Beta: -0.09

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$1.1B

QR
Qube Research
Q2 2026 13F
$22.1M
position
WC
Walleye Capital
Q2 2026 13F

Earnings

Reported Aug 4, 2026

Earnings came in 3.4% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -74.8%
Forward P/E: 4.65
Market cap: $3.8B

Valuation

P/S16.02
P/B3.05

Quality

Operating margin-1381.0%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: IDYA
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $3.75B
Beta: -0.09

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

16.0x

P/B

3.1x

Profit margin

-74.8%

Op margin

-1381.0%

ROE

-16.2%

$14.4M

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$11.2M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for IDYA

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$1.22-3.4%

-$1.18 expected

Next report

What the street expects next

EPS expected

-$1.17

-$1.42 to -$0.84

Revenue expected

$6.8M

13 analysts

Last 30 days

2up0down

Analysts raising estimates

Estimate drift

0.12

Change in 30 days

ROE

-16.2%

ROA-11.5%

Growth

Beta-0.09